Latest Delisting News

Bastion Mining has tabled a recommended $0.08 per share cash offer for Xanadu Mines, representing a significant premium and backed unanimously by Xanadu's independent directors and largest shareholder.

Fintech Chain Limited has applied to delist from the ASX, citing low valuation, poor liquidity, and high costs, aiming to unlock growth capital in China and the US.

The Takeovers Panel has declined to investigate applications challenging Pact Group Holdings’ proposed delisting, signaling regulatory acceptance of the move. The decision clarifies the Panel’s jurisdiction and leaves the delisting process on track.

Hutchison Telecommunications (Amsterdam) B.V., a subsidiary of CK Hutchison Holdings, has made a takeover offer for all shares in Hutchison Telecommunications (Australia) Limited at A$0.032 per share, representing a significant premium to recent trading prices. The offer requires at least 97% acceptance to proceed and aims to delist HTAL from the ASX.

Hutchison Telecommunications (Amsterdam) B.V. has announced an off-market takeover bid for the 12.13% of Hutchison Telecommunications (Australia) Limited shares it does not already own, offering a 52.4% premium. The move aims to consolidate full ownership of the Australian telecom operator.

QBE Insurance Group has finalised the resale and buyback of its US$400 million perpetual capital notes, leading to their cancellation and delisting from the Singapore Exchange.

EDU Holdings has secured ASX approval to voluntarily delist, pending shareholder consent, and announced a $12.4 million equal access share buy-back to provide liquidity options for investors.

NSX Limited has entered a Scheme Implementation Deed with CNSX Markets Inc. for a full acquisition at a 59% premium, subject to shareholder and regulatory approvals. The deal aims to strengthen NSX’s market position and expand its product offerings.

The Reject Shop Limited has entered a recommended scheme of arrangement with Dollarama Inc., offering shareholders $6.68 cash per share, a substantial premium over recent trading prices. The Independent Expert deems the deal fair and reasonable, with a shareholder meeting set for June 23.

Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.

EDU Holdings Limited reported a remarkable turnaround in FY24 with record revenue and profit, yet faces ongoing regulatory headwinds prompting a proposed ASX delisting. The company’s strategic pivot focuses on domestic growth and operational agility.

EDU Holdings Limited plans to voluntarily delist from the ASX, citing low share liquidity and regulatory uncertainty in the international student market. The company proposes a substantial buy-back offer to provide shareholders with an exit opportunity ahead of delisting.